Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.

by Kelly E Dooley, Debra Hanna, Vidya Mave, Kathleen Eisenach, Radojka M Savic
Published 2019-07-01

Secondary attack rate of tuberculosis in urban households in Kampala, Uganda.

by Christopher C Whalen, Sarah Zalwango, Allan Chiunda, LaShaunda Malone, Kathleen Eisenach, Moses Joloba, W Henry Boom, Roy Mugerwa
Published 2011-02-01

Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.

by Robert S Wallis, Rodney Dawson, Sven O Friedrich, Amour Venter, Darcy Paige, Tong Zhu, Annette Silvia, Jason Gobey, Craig Ellery, Yao Zhang, Kathleen Eisenach, Paul Miller, Andreas H Diacon
Published 2014-01-01

Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.

by William R Mac Kenzie, Charles M Heilig, Lorna Bozeman, John L Johnson, Grace Muzanye, Denise Dunbar, Kenneth C Jost, Lois Diem, Beverly Metchock, Kathleen Eisenach, Susan Dorman, Stefan Goldberg
Published 2011-04-01

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis.

by Antonino Catanzaro, Timothy C Rodwell, Donald G Catanzaro, Richard S Garfein, Roberta L Jackson, Marva Seifert, Sophia B Georghiou, Andre Trollip, Erik Groessl, Naomi Hillery, Valeriu Crudu, Thomas C Victor, Camilla Rodrigues, Grace Shou-Yean Lin, Faramarz Valafar, Edward Desmond, Kathleen Eisenach
Published 2015-01-01

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

by Anne-Marie Demers, Soyeon Kim, Sara McCallum, Kathleen Eisenach, Michael Hughes, Linda Naini, Alberto Mendoza-Ticona, Neeta Pradhan, Kim Narunsky, Selvamuthu Poongulali, Sharlaa Badal-Faesen, Caryn Upton, Elizabeth Smith, N. Sarita Shah, Gavin Churchyard, Amita Gupta, Anneke Hesseling, Susan Swindells, for the ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team
Published 2021-02-01

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controll...

by Tara C. Bouton, Patrick P. J. Phillips, Carole D. Mitnick, Charles A. Peloquin, Kathleen Eisenach, Ramonde F. Patientia, Leonid Lecca, Eduardo Gotuzzo, Neel R. Gandhi, Donna Butler, Andreas H. Diacon, Bruno Martel, Juan Santillan, Kathleen Robergeau Hunt, Dante Vargas, Florian von Groote-Bidlingmaier, Carlos Seas, Nancy Dianis, Antonio Moreno-Martinez, C. Robert Horsburgh
Published 2017-11-01